You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Gammopathy

Showing 1 - 25 of 3,784
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 31, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

Recruiting
  • Monoclonal Gammopathy
  • Boston, Massachusetts
  • +1 more
Nov 16, 2022

Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

Not yet recruiting
  • Peripheral Neuropathy
  • Monoclonal Gammopathy of Undetermined Significance
  • Daratumumab and hyaluronidase-fihj
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Sep 14, 2023

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Quality of Life in Asymptomatic Monoclonal Gammopathies

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Study in Monoclonal Gammopathy of Undetermined Significance

Not yet recruiting
  • MGUS
    • Oxford, Oxfordshire, United Kingdom
      Secure Study
    Sep 9, 2022

    Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Curcumin plus Piperine
    • Rochester, New York
      University of Rochester
    Jun 17, 2022

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Whole Foods Plant-based Diet
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

    Recruiting
    • IgA Monoclonal Gammopathy
    • +8 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Oct 18, 2021

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple Myeloma M-Protein Analysis
    • Multiple Myeloma Knowledge Questionnaires
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 26, 2023

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Metformin XR
    • Placebo
    • Boston, Massachusetts
    • +6 more
    Oct 3, 2022

    A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

    Recruiting
    • Multiple Myeloma
    • +11 more
    • No intervention
    • Beijing, China
      Peking University First Hospital
    Apr 21, 2022

    Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

    Not yet recruiting
    • Immune System Diseases
    • +15 more
    • observational cohort study
    • (no location specified)
    Jul 23, 2023

    Multicenter Case Series

    Recruiting
    • Monoclonal Gammopathy of Renal Significance
      • San Fermo Della Battaglia, Como, Italy
      • +7 more
      Jan 23, 2023

      Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Multiple Myeloma
      • Plant based meals
      • Basking Ridge, New Jersey
      • +6 more
      Apr 11, 2022

      Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)

      Not yet recruiting
      • Monoclonal Gammopathy
      • +2 more
      • DKK1
      • Cleveland, Ohio
      • +1 more
      Nov 29, 2021

      Two Biologically and Clinically Distinct Entities: Progressive

      Recruiting
      • Multiple Myeloma
      • +2 more
        • Miami, Florida
          University of Miami Hospitals
        Jun 7, 2022

        Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

        Recruiting
        • Monoclonal Gammopathies
        • +2 more
        • Observational studies, no intervention
        • Guangzhou, Guangdong, China
          Zhujiang Hospital of Southern Medical University
        Jan 6, 2023

        Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Cryoglobulinemic Vasculitis Trial (Isatuximab Injection)

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • Isatuximab Injection
        • (no location specified)
        Oct 28, 2021

        Screening to Improve Survival in AL Amyloidosis

        Recruiting
        • Smoldering Multiple Myeloma
        • Monoclonal Gammopathy of Undetermined Significance
          • Orange, California
          • +5 more
          Nov 16, 2022

          Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

          Active, not recruiting
          • Monoclonal Gammopathy of Undetermined Significance
          • Clinical follow-up 1
          • +5 more
          • Reykjavík, Iceland
            University of Iceland
          Feb 28, 2022

          Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

          Recruiting
          • Adenine Phosphoribosyltransferase Deficiency
          • +83 more
            • Bristol, South West, United Kingdom
              Zoe Plummer
            Sep 26, 2023

            Progression to Myeloma in Asymptomatic Monoclonal Gammopathies

            Recruiting
            • Monoclonal Gammopathy of Undetermined Significance
            • Smoldering Plasma Cell Myeloma
            • Biospecimen Collection
            • Laboratory Biomarker Analysis
            • Houston, Texas
              M D Anderson Cancer Center
            Oct 4, 2021